DIABETIC DRUGS CAUSING CANCER
Facing growing evidence that some of America’s top-selling diabetes medicines could lead to pancreatic disease, federal regulators on Thursday opened an unusual review of drugs from Merck & Co., Bristol-Myers Squibb Co., BMY and other pharmaceutical makers.




